These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1661 related articles for article (PubMed ID: 25838377)

  • 1. Cancer and the microbiota.
    Garrett WS
    Science; 2015 Apr; 348(6230):80-6. PubMed ID: 25838377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 'fit' microbiota to potentiate cancer immunotherapy.
    Rescigno M
    Genome Med; 2015 Dec; 7():131. PubMed ID: 26689196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbes and Cancer.
    Dzutsev A; Badger JH; Perez-Chanona E; Roy S; Salcedo R; Smith CK; Trinchieri G
    Annu Rev Immunol; 2017 Apr; 35():199-228. PubMed ID: 28142322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microbiome and human cancer.
    Sepich-Poore GD; Zitvogel L; Straussman R; Hasty J; Wargo JA; Knight R
    Science; 2021 Mar; 371(6536):. PubMed ID: 33766858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of microbiota in response to cancer immunotherapy.
    Inamura K
    Semin Cancer Biol; 2020 Oct; 65():164-175. PubMed ID: 31911189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy.
    Wan X; Song M; Wang A; Zhao Y; Wei Z; Lu Y
    Front Immunol; 2021; 12():747914. PubMed ID: 34745119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota Manipulated to Enhance Immunity.
    Cancer Discov; 2019 Jul; 9(7):822. PubMed ID: 31072874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
    Dzutsev A; Goldszmid RS; Viaud S; Zitvogel L; Trinchieri G
    Eur J Immunol; 2015 Jan; 45(1):17-31. PubMed ID: 25328099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-microbe cross talk in cancer therapy.
    Vanhoecke B; Stringer A
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):174-81. PubMed ID: 25872117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy.
    Joukar F; Mavaddati S; Mansour-Ghanaei F; Samadani AA
    J Gastrointest Cancer; 2020 Jun; 51(2):363-378. PubMed ID: 31025167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and the microbiome.
    Gunjur A
    Lancet Oncol; 2020 Jul; 21(7):888. PubMed ID: 32563279
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of Microbiome in Modulating Immune Responses in Cancer.
    Bose M; Mukherjee P
    Mediators Inflamm; 2019; 2019():4107917. PubMed ID: 31308831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting bacteria for cancer immunotherapy.
    Kwon SY; Thi-Thu Ngo H; Son J; Hong Y; Min JJ
    Nat Rev Clin Oncol; 2024 Aug; 21(8):569-589. PubMed ID: 38840029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome and Its Implications in Cancer Immunotherapy.
    Choudhry H
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome in anti-cancer therapy.
    Bashiardes S; Tuganbaev T; Federici S; Elinav E
    Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota modulation of myeloid cells in cancer therapy.
    Goldszmid RS; Dzutsev A; Viaud S; Zitvogel L; Restifo NP; Trinchieri G
    Cancer Immunol Res; 2015 Feb; 3(2):103-9. PubMed ID: 25660553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the microbiota in response to and recovery from cancer therapy.
    Blake SJ; Wolf Y; Boursi B; Lynn DJ
    Nat Rev Immunol; 2024 May; 24(5):308-325. PubMed ID: 37932511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?
    Finlay BB; Goldszmid R; Honda K; Trinchieri G; Wargo J; Zitvogel L
    Nat Rev Immunol; 2020 Sep; 20(9):522-528. PubMed ID: 32661409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.